UK markets closed

Novo Nordisk A/S (0QIU.IL)

IOB - IOB Delayed price. Currency in DKK
Add to watchlist
842.40-35.65 (-4.06%)
At close: 07:12PM BST
Full screen
Previous close878.05
Open854.80
Bid841.80 x 0
Ask859.20 x 0
Day's range826.50 - 878.10
52-week range86.66 - 932.00
Volume1,584,931
Avg. volume1,003,704
Market cap3.537T
Beta (5Y monthly)0.21
PE ratio (TTM)56.69
EPS (TTM)14.86
Earnings date03 May 2024
Forward dividend & yield7.08 (1.04%)
Ex-dividend date18 Aug 2023
1y target estN/A
  • Yahoo Finance

    Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market

    Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.

  • Insider Monkey

    Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript

    Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript May 2, 2024 Novo Nordisk A/S misses on earnings expectations. Reported EPS is $0.7 EPS, expectations were $0.77. NVO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day! And thank […]

  • Globe Newswire

    Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

    Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have reported the transactions to Novo Nordisk and have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the